These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24234257)

  • 1. Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis.
    Keren S; Shoude Z; Lu Z; Beibei Y
    Tumour Biol; 2014 Mar; 35(3):2285-95. PubMed ID: 24234257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis.
    Sun W; Long G; Wang J; Mei Q; Liu D; Hu G
    Head Neck; 2014 Oct; 36(10):1508-16. PubMed ID: 23996630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
    Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
    Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF
    Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Hong X; Wang G; Xu G; Shi W; Wang T; Rong Z; Mo C
    Medicine (Baltimore); 2022 Jan; 101(3):e28507. PubMed ID: 35060503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: A systematic review and meta-analysis.
    Nie D; Wang X; Sun M; Feng Z; Pei F; Liu W; Wang Z; Han F
    Radiother Oncol; 2021 May; 158():13-20. PubMed ID: 33587969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
    Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J
    Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.
    Wheeler S; Siwak DR; Chai R; LaValle C; Seethala RR; Wang L; Cieply K; Sherer C; Joy C; Mills GB; Argiris A; Siegfried JM; Grandis JR; Egloff AM
    Clin Cancer Res; 2012 Apr; 18(8):2278-89. PubMed ID: 22351687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineural invasion as a prognostic factor in head and neck squamous cell carcinoma: a systematic review and meta-analysis.
    Zhu J; Zhou R; Wang Y; Yu M
    Acta Otolaryngol; 2019 Nov; 139(11):1038-1043. PubMed ID: 31464544
    [No Abstract]   [Full Text] [Related]  

  • 11. A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck.
    Tandon S; Tudur-Smith C; Riley RD; Boyd MT; Jones TM
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):574-87. PubMed ID: 20142252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis.
    Chen X; Liang R; Lai L; Chen K; Zhu X
    Front Oncol; 2021; 11():697369. PubMed ID: 34490092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
    Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
    World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis.
    Zhao Z; Ge J; Sun Y; Tian L; Lu J; Liu M; Zhao Y
    Oral Oncol; 2012 Sep; 48(9):761-7. PubMed ID: 22455948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancer.
    Pajares B; Perez-Villa L; Trigo JM; Toledo MD; Alvarez M; Jimenez B; Medina JA; de Luque V; Jerez JM; Alba E
    Clin Transl Oncol; 2014 Apr; 16(4):418-24. PubMed ID: 24193865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of epidermal growth factor receptor in head and neck cancer: a meta-analysis.
    Zhu X; Zhang F; Zhang W; He J; Zhao Y; Chen X
    J Surg Oncol; 2013 Nov; 108(6):387-97. PubMed ID: 24038070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma.
    Chung CH; Zhang Q; Hammond EM; Trotti AM; Wang H; Spencer S; Zhang HZ; Cooper J; Jordan R; Rotman MH; Ang KK
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):331-8. PubMed ID: 20732768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
    Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis.
    Bišof V; Zajc Petranović M; Rakušić Z; Samardžić KR; Juretić A
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2305-17. PubMed ID: 26179868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16(INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: A systematic review and meta-analysis.
    Su Y; Cui J; Xu D; Wang M; Xu T; Tian H; Han F
    Crit Rev Oncol Hematol; 2018 Apr; 124():11-20. PubMed ID: 29548481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.